Use of glycosylated hemoglobin and C-peptide levels in the diagnosis and prevention of type 1 diabetes mellitus as an immune-related adverse event secondary to treatment with immunotherapy in solid ...
Philadelphia, PA - Two new studies suggest that glycosylated hemoglobin level is an independent risk factor for cardiovascular disease, regardless of diabetes status. The reports appear in the ...